341 related articles for article (PubMed ID: 11907201)
21. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
22. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
[TBL] [Abstract][Full Text] [Related]
23. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
24. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
25. Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses.
Iyer AV; Pahar B; Chouljenko VN; Walker JD; Stanfield B; Kousoulas KG
Virol J; 2013 Oct; 10():317. PubMed ID: 24165088
[TBL] [Abstract][Full Text] [Related]
26. Blockade of LAG-3 Immune Checkpoint Combined With Therapeutic Vaccination Restore the Function of Tissue-Resident Anti-viral CD8
Roy S; Coulon PG; Srivastava R; Vahed H; Kim GJ; Walia SS; Yamada T; Fouladi MA; Ly VT; BenMohamed L
Front Immunol; 2018; 9():2922. PubMed ID: 30619285
[TBL] [Abstract][Full Text] [Related]
27. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
28. Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function.
Walker J; Leib DA
Vaccine; 1998 Jan; 16(1):1-5. PubMed ID: 9607001
[TBL] [Abstract][Full Text] [Related]
29. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.
Morrison LA; Zhu L; Thebeau LG
J Virol; 2001 Feb; 75(3):1195-204. PubMed ID: 11152492
[TBL] [
